By Paul A. Harris
Portland, Ore., March 11 – Endo International plc priced an upsized $1.295 billion issue of eight-year senior secured first-lien notes (B3/B+) at par to yield 6 1/8% in a Thursday drive-by, according to market sources.
The issue size increased from $1 billion, representing the shift of $295 million of proceeds from a concurrent bank loan.
The yield printed at the tight end of yield talk in the 6¼% area. Initial guidance was in the 6½% area.
The deal was heard to be playing to $4.9 billion of demand, a trader said.
JPMorgan was at the left of a syndicate of deal managers that also included Citigroup, Barclays, BofA, Deutsche Bank, Goldman Sachs, RBC and Siebert Williams Shank.
As a result of the shift of proceeds to the notes from the loan, the loan decreased to $2 billion from $2.295 billion.
The issuing entities, Endo Luxembourg Finance Co. I Sarl and Endo U.S. Inc., are wholly owned subsidiaries of Endo International.
The Dublin, Ireland-based specialty pharmaceutical company plans to use the proceeds plus proceeds from the new senior secured term loan to refinance its existing term loan.
Issuers: | Endo Luxembourg Finance Co. I Sarl and Endo U.S. Inc.
|
Amount: | $1.295 billion
|
Tenor: | Eight years
|
Securities: | Senior secured first-lien notes
|
Managers: | JPMorgan, Citigroup, Barclays, BofA, Deutsche Bank, Goldman Sachs, RBC and Siebert Williams Shank
|
Coupon: | 6 1/8%
|
Price: | Par
|
Yield: | 6 1/8%
|
Call protection: | Three years
|
Trade date: | March 11
|
Ratings: | Moody's: B3
|
| S&P: B+
|
Distribution: | Rule 144A and Regulation S for life
|
Price talk: | 6¼% area
|
Marketing: | Drive-by
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.